已發(fā)表的部分文獻: 標題:Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells.作者:Neri F, Zippo A, Krepelova A, Cherubini A, Rocchigiani M, Oliviero S;雜志名稱:Mol Cell Biol 標題:Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.作者:Fujino T, Hasebe N;雜志名稱:BMC Nephrol 標題:Novel detection of post-translational modifications in human monocyte-derived dendritic cells after chronic alcohol exposure: Role of inflammation regulator H4K12ac.作者:Parira T, Figueroa G, Laverde A, Casteleiro G, Gomez Hernandez ME, Fernandez-Lima F, Agudelo M;雜志名稱:Sci Rep 標題:The role of RIPK1 mediated cell death in acute on chronic liver failure.作者:Kondo T, Macdonald S, Engelmann C, Habtesion A, Macnaughtan J, Mehta G, Mookerjee RP, Davies N, Pavesi M, Moreau R, Angeli P, Arroyo V, Andreola F, Jalan R;雜志名稱:Cell Death Dis Epigentek 公司是全球領先的表觀遺傳學相關研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。